Using Near-Infrared Light to Better Understand Peripheral Artery Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe University of Texas at Arlington

About this trial

The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes.

Specific aims include:

Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction.

Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.

Eligibility criteria

Qualifiers

Cases, Aim 1

18 or older

willing to participate under the conditions described in the informed consent form (ICF)

eligible to sign the ICF

Disqualifiers

Cases, Aim 1

Ankle-Brachial Index >0.9 or <0.4

isolated disease in aorta/iliac vessels

unstable angina or myocardial infarction in past 12 months

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

120 Participants
are grouped into 2 trial groups